In a significant development for India’s healthcare manufacturing sector, Lords Mark Industries Limited has received a major regulatory approval that strengthens its position in the global diagnostics market. The company has been granted a licence under the Medical Devices Rules, 2017 to manufacture a high-risk medical device, marking an important milestone in its growth journey.

This update, disclosed under SEBI LODR Regulation 30 disclosure, highlights the company’s expansion into advanced medical technology and its ambition to become a key player in international healthcare markets. The approval has been granted by the Central Licensing Authority, which oversees the regulation of medical devices in the country.

Lords Mark Medical Device Licence India Milestone

The Lords Mark medical device licence India achievement is particularly noteworthy because it places the company among a very select group. According to the disclosure, Lords Mark is only the second company in India and one of just nine companies globally to receive such a licence for this category of device.

This distinction underscores the technical expertise and compliance standards maintained by the company. In the highly regulated field of medical devices, obtaining approval for high-risk products is a complex process that requires stringent quality checks and adherence to international standards.

HIV Self Test Kit Export India Expansion

The approved product, branded as LordsMed HIV 1&2 Self Test, falls under the category of HIV self test kit export India. It is designed as a single-use, qualitative in-vitro diagnostic device that can detect and differentiate between HIV-1 and HIV-2 antibodies using human whole blood.

This type of device is particularly important in improving accessibility to testing, as it allows individuals to perform the test privately. The focus on export markets such as Africa, Latin America, and Europe highlights the company’s strategy to address global healthcare needs.

These regions often face challenges in accessing reliable diagnostic tools, and the availability of such self-testing kits can play a crucial role in early detection and prevention of disease spread.

Class D IVD Device India Approval

The product has been classified as a Class D IVD device, which represents the highest risk category under medical device regulations. The Class D IVD device India approval indicates that the product meets the most stringent regulatory requirements, ensuring high levels of accuracy and reliability.

Class D devices are typically used for detecting life-threatening conditions, making regulatory oversight critical. The approval reflects the company’s capability to manufacture devices that meet global safety and performance standards.

Manufacturing Facility and Licence Details

The licence has been issued for the company’s manufacturing facility located in Vasai, Maharashtra, which is equipped to handle advanced production processes. The licence details include:

• Licence Number: MFG/IVD/2023/000058 (Endorsement No. 8)
• Date of Grant: January 14, 2026
• Issuing Authority: Central Licensing Authority

The facility’s approval ensures that the company can produce the device in compliance with all regulatory norms, including quality control and safety protocols.

Healthcare Diagnostics Export India Company Growth

The development marks a significant step forward for healthcare diagnostics export India company growth. By focusing on export markets, Lords Mark is positioning itself as a global supplier of high-quality diagnostic products.

India has been increasingly recognised as a hub for pharmaceutical and medical device manufacturing, and this approval further strengthens that reputation. The company’s entry into the export segment aligns with national efforts to boost healthcare exports and expand the country’s global footprint.

LordsMed HIV Test Kit Export Markets Strategy

The LordsMed HIV test kit export markets strategy focuses on regions with high demand for affordable and reliable diagnostic solutions. Africa, Latin America, and parts of Europe represent key markets where such products can have a meaningful impact.

By targeting these regions, the company aims to contribute to global health initiatives while also expanding its business operations. The export-oriented approach ensures that the product meets international standards and regulatory requirements in multiple jurisdictions.

Indian Company Global Medical Device Licence Recognition

The recognition of Lords Mark as an Indian company global medical device licence holder highlights the growing capabilities of Indian firms in advanced manufacturing. Competing at a global level requires not only technical expertise but also compliance with diverse regulatory frameworks.

This achievement demonstrates that Indian companies are increasingly capable of meeting these challenges and delivering high-quality products to international markets.

Role of SEBI LODR Regulation 30 Disclosure

The announcement was made in accordance with SEBI LODR Regulations, 2015, which mandates timely disclosure of material events by listed companies. Such transparency ensures that investors and stakeholders are informed about significant developments that could impact the company’s performance.

The disclosure reflects the importance of regulatory compliance in maintaining investor confidence and supporting corporate governance standards.

Impact on Healthcare and Diagnostics Sector

The introduction of advanced self-testing kits has the potential to transform the healthcare landscape, particularly in regions with limited access to medical facilities. The availability of reliable and easy-to-use diagnostic tools can improve early detection rates and reduce the burden on healthcare systems.

For diseases like HIV, early diagnosis is crucial for effective treatment and prevention. The development of self-test kits represents a significant step towards achieving global health goals.

Conclusion

The grant of a manufacturing licence to Lords Mark Industries Limited marks a major milestone in the company’s journey and in the broader HIV self test kit export India landscape. By entering the high-risk medical device segment, the company has demonstrated its commitment to innovation, quality, and global expansion.

With the ability to manufacture and export Class D IVD devices, Lords Mark is well positioned to make a meaningful impact in international healthcare markets. The approval not only strengthens its business prospects but also highlights India’s growing role in the global medical device industry.

As the demand for advanced diagnostic solutions continues to rise, developments like these will play a crucial role in shaping the future of healthcare and reinforcing India’s position as a global manufacturing hub.

Join our Telegram Channel for Latest News and Regular Updates.

Start your Mutual Fund Journey  by Opening Free Account in Asset Plus.